Dr. Corinna Pohl’s Post

Join us at our upcoming webinar to explore innovations in stem cell workflows and 3D disease models! Learn about iPSC characterization, suspension culture, and advanced differentiation techniques. Plus, discover how to leverage novel protocols for neural, cardiac, and hemopoietic organoid models. #thermofisheremp

Join us at our upcoming webinar to explore innovations in stem cell workflows and 3D disease models! Learn about iPSC characterization, suspension culture, and advanced differentiation techniques. Plus, discover how to leverage novel protocols for neural, cardiac, and hemopoietic organoid models. #thermofisheremp

Join us at our upcoming webinar to explore innovations in stem cell workflows and 3D disease models! Learn about iPSC characterization, suspension culture, and advanced differentiation techniques. Plus, discover how to leverage novel protocols for neural, cardiac, and hemopoietic organoid models. #thermofisheremp

Join us at our upcoming webinar to explore innovations in stem cell workflows and 3D disease models! Learn about iPSC characterization, suspension culture, and advanced differentiation techniques. Plus, discover how to leverage novel protocols for neural, cardiac, and hemopoietic organoid models. #thermofisheremp

Join us at our upcoming webinar to explore innovations in stem cell workflows and 3D disease models! Learn about iPSC characterization, suspension culture, and advanced differentiation techniques. Plus, discover how to leverage novel protocols for neural, cardiac, and hemopoietic organoid models. #thermofisheremp

Join us at our upcoming webinar to explore innovations in stem cell workflows and 3D disease models! Learn about iPSC characterization, suspension culture, and advanced differentiation techniques. Plus, discover how to leverage novel protocols for neural, cardiac, and hemopoietic organoid models. #thermofisheremp

Join us at our upcoming webinar to explore innovations in stem cell workflows and 3D disease models! Learn about iPSC characterization, suspension culture, and advanced differentiation techniques. Plus, discover how to leverage novel protocols for neural, cardiac, and hemopoietic organoid models. #thermofisheremp

Advancements in biomedical engineering, like 3D bioprinting and electrospinning, are enhancing stem cell therapies for treating limbal stem cell deficiency (LSCD), a condition leading to blindness. This review paper does a good job highlighting the various approaches and biomaterials for treating this blindness, including using collagen and hyaluronic acid (Advanced BioMatrix) combined with 3D bioprinting or electrospinning. Exciting progress in this area holds promise for better treatments and improved patient care. Read the full article here: https://lnkd.in/gSfMDgeS #StemCells #BiomedicalEngineering #Innovation #Healthcare

🚀 Exciting Research Alert! 🚀 We're thrilled to share that our products at Antibodies.com played a crucial role in a groundbreaking study on retinal development, recently published in Nature Communications. 👉 The research offers a detailed single-cell analysis of retinal progenitor cell (RPC) specification and differentiation during human retinal development up to midgestation. 👉The team identified early, late, and transient neurogenic progenitors, mapping their transition to various retinal neurons. 👉Through single-cell RNA-Seq and spatial transcriptomics, they revealed the transient presence of early RPCs in the ciliary margin zone, decreasing from 8 post-conception weeks. 👉The study found that inhibiting certain transcription factors led to the loss of cycling progenitors and retinal identity in pluripotent stem cell-derived organoids. This work not only deepens our understanding of human retinal development but also opens new avenues for stem cell research and regenerative medicine. We’re proud that Antibodies.com's tools and reagents supported this innovative research. Keep pushing the boundaries of science! 💡🔬 Read the full study here: https://lnkd.in/e5VdT-qt #Antibodies #Antibody #Research #Science #RetinalDevelopment #SingleCellAnalysis #StemCellResearch #ProudContributor #ScientificBreakthroughs #NatureCommunications

As we close out 2024, we're excited to share the incredible strides Dystrogen Therapeutics has made this year in advancing cutting-edge therapies for #Duchenne Muscular Dystrophy (DMD). From groundbreaking research to regulatory milestones, here are the highlights:   2024 Achievements 🧬 Peer-Reviewed Publications: 1. 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗖𝗵𝗶𝗺𝗲𝗿𝗶𝗰 𝗖𝗲𝗹𝗹 #𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗳𝗼𝗿 𝗗𝘂𝗰𝗵𝗲𝗻𝗻𝗲 𝗠𝘂𝘀𝗰𝘂𝗹𝗮𝗿 𝗗𝘆𝘀𝘁𝗿𝗼𝗽𝗵𝘆 Published in Int J Mol Sci. ✨ Focus: Advanced development of chimeric cell therapy approaches for DMD. 2. 𝗠𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺𝘀 𝗼𝗳 𝗖𝗵𝗶𝗺𝗲𝗿𝗶𝗰 #𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗶𝗻 𝗗𝘂𝗰𝗵𝗲𝗻𝗻𝗲 𝗠𝘂𝘀𝗰𝘂𝗹𝗮𝗿 𝗗𝘆𝘀𝘁𝗿𝗼𝗽𝗵𝘆 Published in Biomedicines. ✨ Focus: Understanding the cellular and molecular mechanisms behind this innovative therapy. 3. 𝗖𝗵𝗶𝗺𝗲𝗿𝗶𝗰 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗧𝗿𝗮𝗻𝘀𝗳𝗲𝗿𝘀 𝗛𝗲𝗮𝗹𝘁𝗵𝘆 𝗗𝗼𝗻𝗼𝗿 𝗠𝗶𝘁𝗼𝗰𝗵𝗼𝗻𝗱𝗿𝗶𝗮 𝗶𝗻 𝗗𝘂𝗰𝗵𝗲𝗻𝗻𝗲 𝗠𝘂𝘀𝗰𝘂𝗹𝗮𝗿 #𝗗𝘆𝘀𝘁𝗿𝗼𝗽𝗵𝘆 Published in Stem Cell Rev Rep. ✨ Focus: Mitochondrial transfer and its transformative potential for DMD patients. 4. 𝗖𝗵𝗶𝗺𝗲𝗿𝗶𝗰 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗮𝘀 𝗮 𝗡𝗼𝘃𝗲𝗹 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗳𝗼𝗿 𝗗𝘂𝗰𝗵𝗲𝗻𝗻𝗲 #𝗠𝘂𝘀𝗰𝘂𝗹𝗮𝗿 𝗗𝘆𝘀𝘁𝗿𝗼𝗽𝗵𝘆 (𝗗𝗠𝗗) 𝗮𝗻𝗱 𝗠𝘂𝘀𝗰𝗹𝗲 𝗥𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 Published in Biomolecules. ✨ Focus: Regenerative applications of chimeric cell therapies for muscle repair. 5. 𝗔𝗺𝗲𝗹𝗶𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗠𝗼𝗿𝗽𝗵𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗶𝗻 #𝗖𝗮𝗿𝗱𝗶𝗮𝗰, #𝗥𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆, 𝗮𝗻𝗱 #𝗦𝗸𝗲𝗹𝗲𝘁𝗮𝗹 𝗠𝘂𝘀𝗰𝗹𝗲𝘀 𝗙𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝗜𝗻𝘁𝗿𝗮𝗼𝘀𝘀𝗲𝗼𝘂𝘀 𝗔𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗛𝘂𝗺𝗮𝗻 𝗗𝘆𝘀𝘁𝗿𝗼𝗽𝗵𝗶𝗻 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝗖𝗵𝗶𝗺𝗲𝗿𝗶𝗰 (𝗗𝗘𝗖) 𝗖𝗲𝗹𝗹𝘀 Published in Biomedicines. ✨ Focus: Significant improvements across multiple muscle systems with DEC therapy.